ING Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-200,000
Closed -$8.43M 691
2023
Q2
$8.43M Hold
200,000
0.06% 208
2023
Q1
$7.12M Buy
+200,000
New +$7.26M 0.07% 206
2019
Q1
Sell
-9,336
Closed -$367K 842
2018
Q4
$367K Buy
9,336
+54
+0.6% +$2.51K 0.01% 536
2018
Q3
$478K Buy
9,282
+781
+9% +$38.2K 0.01% 526
2018
Q2
$399K Sell
8,501
-70
-0.8% -$2.9K 0.01% 531
2018
Q1
$304K Buy
8,571
+69
+0.8% +$2.7K 0.01% 616
2017
Q4
$371K Buy
8,502
+1,618
+24% +$75.6K 0.01% 593
2017
Q3
$360K Buy
6,884
+303
+5% +$16.9K 0.01% 629
2017
Q2
$385K Buy
+6,581
New +$342K 0.01% 605

Other funds holding SYNH

ING Group's SYNH Position: Q3 2023 in Review

ING Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 200,000 shares — an estimated $8.43M sold.

ING Group first reported a position in SYNH in Q2 2017 and held it in 9 quarters. The position peaked at $8.43M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • ING Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • ING Group sold 200,000 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $8.43M.
  • ING Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2017 and held it in 9 quarters.
  • ING Group's Syneos Health, Inc. Class A Common Stock position peaked at $8.43M in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on ING Group's 13F filing for Q3 2023, filed 27 Oct 2023.